Published in Dose Response on June 25, 2010
A comparison of association methods for cytotoxicity mapping in pharmacogenomics. Front Genet (2011) 0.96
Beyond IC50s: Towards Robust Statistical Methods for in vitro Association Studies. J Pharmacogenomics Pharmacoproteomics (2014) 0.91
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines. Front Pharmacol (2017) 0.75
Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures. Drug Metab Dispos (2016) 0.75
A comparison of analytical methods for genetic association studies. Genet Epidemiol (2008) 1.61
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma. Lab Invest (2007) 1.33
Neural networks for genetic epidemiology: past, present, and future. BioData Min (2008) 1.12
Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res (1994) 1.08
Alternative Cross-Over Strategies and Selection Techniques for Grammatical Evolution Optimized Neural Networks. Genet Evol Comput Conf (2006) 1.07
Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos (2008) 1.06
Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm. J Mol Graph Model (2007) 1.01
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study. J Infect Dis (2010) 1.91
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study. Environ Health Perspect (2015) 1.37
Shift work in nurses: contribution of phenotypes and genotypes to adaptation. PLoS One (2011) 1.25
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel. Breast Cancer Res Treat (2012) 1.23
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. Pharmacogenet Genomics (2012) 1.23
Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials. J Altern Complement Med (2010) 1.15
Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL. Cancer Res (2013) 1.14
Twice-daily application of HIV microbicides alter the vaginal microbiota. MBio (2012) 1.11
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics (2014) 1.00
Characterization of conserved and nonconserved imprinted genes in swine. Biol Reprod (2009) 0.98
Multivariate methods and software for association mapping in dose-response genome-wide association studies. BioData Min (2012) 0.96
A comparison of association methods for cytotoxicity mapping in pharmacogenomics. Front Genet (2011) 0.96
A comparison of internal validation techniques for multifactor dimensionality reduction. BMC Bioinformatics (2010) 0.92
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity. Clin Cancer Res (2013) 0.91
Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium. Front Genet (2013) 0.91
A new explained-variance based genetic risk score for predictive modeling of disease risk. Stat Appl Genet Mol Biol (2012) 0.90
Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res (2011) 0.90
An R package implementation of multifactor dimensionality reduction. BioData Min (2011) 0.88
Quality of reporting on randomised controlled trials of auriculotherapy for pain. Acupunct Med (2011) 0.87
Loss of power in two-stage residual-outcome regression analysis in genetic association studies. Genet Epidemiol (2012) 0.86
Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes (2011) 0.85
Multifactor dimensionality reduction as a filter-based approach for genome wide association studies. Front Genet (2011) 0.83
Differences in X-chromosome transcriptional activity and cholesterol metabolism between placentae from swine breeds from Asian and Western origins. PLoS One (2013) 0.82
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy. Breast Cancer Res Treat (2014) 0.82
The effect of retrospective sampling on estimates of prediction error for multifactor dimensionality reduction. Ann Hum Genet (2011) 0.82
A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure. Pharmacogenet Genomics (2016) 0.82
Naturally occuring canine cancers: powerful models for stimulating pharmacogenomic advancement in human medicine. Pharmacogenomics (2013) 0.81
Effects of acepromazine maleate on platelet function assessed by use of adenosine diphosphate activated- and arachidonic acid- activated modified thromboelastography in healthy dogs. Am J Vet Res (2012) 0.81
Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples. J Proteome Res (2015) 0.80
A Balanced Accuracy Fitness Function Leads to Robust Analysis using Grammatical Evolution Neural Networks in the Case of Class Imbalance. Genet Evol Comput Conf (2008) 0.79
Global tests of P-values for multifactor dimensionality reduction models in selection of optimal number of target genes. BioData Min (2012) 0.79
Prevalence of onychectomy in cats presented for veterinary care near Raleigh, NC and educational attitudes toward the procedure. Vet Anaesth Analg (2013) 0.79
Comparison of venous sampling methods for thromboelastography in clinically normal dogs. Am J Vet Res (2012) 0.79
Risk score modeling of multiple gene to gene interactions using aggregated-multifactor dimensionality reduction. BioData Min (2013) 0.78
A comparison of multifactor dimensionality reduction and L1-penalized regression to identify gene-gene interactions in genetic association studies. Stat Appl Genet Mol Biol (2011) 0.78
Evaluation of thromboelastography for prediction of clinical bleeding in thrombocytopenic dogs after total body irradiation and hematopoietic cell transplantation. Am J Vet Res (2014) 0.77
Discussion of a genome-wide association approach to determine HIV-1 set point in African Americans. J Infect Dis (2010) 0.75
A predictive model for efavirenz dosing. Pharmacogenomics (2012) 0.75
Do genetic polymorphisms of nevirapine metabolic, transport and antigen recognition enzymes play a role in nevirapine toxicity risk? Pharmacogenomics (2012) 0.75
A comparison of internal model validation methods for multifactor dimensionality reduction in the case of genetic heterogeneity. BMC Res Notes (2012) 0.75
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care. Pharmacogenomics (2010) 0.75
Are plasma level and CYP genotypes predictors of liver injury in an Ethiopian population? Pharmacogenomics (2012) 0.75